USC Buys WaferGen SmartChip System for Oncology Drug Discovery

USC, which was an early-access customer for SmartChip prior to its full commercial launch in August, will use the system to discover and validate biomarkers for pancreatic and colorectal cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.